CVMAX
Price
$16.88
Change
-$0.29 (-1.69%)
Updated
Sep 6 closing price
RNWFX
Price
$79.55
Change
-$1.12 (-1.39%)
Updated
Sep 6 closing price
Ad is loading...

CVMAX vs RNWFX

Header iconCVMAX vs RNWFX Comparison
Open Charts CVMAX vs RNWFXBanner chart's image
Calvert Emerging Markets Equity A
Price$16.88
Change-$0.29 (-1.69%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$79.55
Change-$1.12 (-1.39%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CVMAX vs RNWFX Comparison Chart
Loading...
VS
CVMAX vs. RNWFX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVMAX is a StrongBuy and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.1B vs. CVMAX (1.52B). RNWFX pays higher dividends than CVMAX: RNWFX (1.51) vs CVMAX (0.70). CVMAX was incepted earlier than RNWFX: CVMAX (12 years) vs RNWFX (22 years). CVMAX is a more actively managed with annual turnover of: 59.00 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than CVMAX: RNWFX (250) vs CVMAX (1000). RNWFX annual gain was more profitable for investors over the last year : 11.53 vs. CVMAX (8.82). RNWFX return over 5 years is better than : 22.38 vs. CVMAX (8.08).
CVMAXRNWFXCVMAX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years22 years-
Gain YTD5.8757.24581%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.52B60.1B3%
Annual Yield % from dividends0.701.5147%
Returns for 1 year8.8211.5376%
Returns for 3 years-21.90-15.44142%
Returns for 5 years8.0822.3836%
Returns for 10 years26.6135.7175%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EGO16.410.29
+1.80%
Eldorado Gold Corp
BIP31.38-0.08
-0.25%
Brookfield Infrastructure Partners LP
KTRA0.17N/A
-2.51%
Kintara Therapeutics
LCTX0.87-0.03
-3.17%
Lineage Cell Therapeutics
NUVB2.88-0.13
-4.32%
Nuvation Bio